Mauna Kea Technologies SA (LON:0P5I)

Market Cap	4.99M
Revenue (ttm)	6.96M
Net Income (ttm)	-8.60M
Shares Out	n/a
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,108
Average Volume	39,694
Open	0.0840
Previous Close	0.0900
Day's Range	0.0840 - 0.0860
52-Week Range	0.0700 - 0.5190
Beta	1.44
RSI	36.37
Earnings Date	Oct 2, 2025

About Mauna Kea Technologies

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 65
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P5I

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.

Financial numbers in EUR